Contributors

Ruben Abagyan, Bioinformatics and Systems Biology Graduate Program, University of California, La Jolla, CA

Elfrida R. Benjamin, Amicus Therapeutics, Cranbury, NJ

Magdalena Birker-Robaczewska, Actelion Pharmaceuticals Ltd., Allschwil, Switzerland

Michel Bouvier, Département de Biochimie,Université de Montréal,Montréal, Quebec, Canada

Moritz Bunemann, Department of Pharmacology and Toxicology, Philipps-Universitaet Marburg, Marburg, Germany

Nathalie Clement, Institut Cochin, Université Paris Descartes, Department of Cell Biology, Paris, France

Arthur Christopoulos, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Victoria, Australia

Maria Teresa Dell'Anno, Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy

Maoqing Dong, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, AZ

Richard M. Eglen, PerkinElmer Life and Analytical Sciences, Waltham, MA

James C. Errey, Heptares Therapeutics Limited, BioPark, Welwyn Garden City, Hertfordshire, UK

Michael Freissmuth, Institute of Pharmacology, Center of Biomolecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria

John Gatfield, Actelion Pharmaceuticals Ltd., Allschwil, Switzerland

Karen J. Gregory, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Victoria, Australia

Christian W. Gruber, Institute of Pharmacology, Center of Biomolecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria

Ingrid Gsandtner, Institute of Pharmacology, Center of Biomolecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria

Kaleeckal G. Harikumar, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, AZ

Stephen J. Hill, The University of Nottingham, Institute of Cell Signalling, School of Biomedical Sciences, Queen's Medical Centre, Nottingham, UK

Carsten Hoffmann, Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany

Nicholas D. Holliday, The University of Nottingham, Institute of Cell Signalling, School of Biomedical Sciences, Queen's Medical Centre, Nottingham, UK

Ralf Jockers, Institut Cochin, Université Paris Descartes, Department of Cell Biology, Paris, France

Vsevolod Katritch, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA

Terry Kenakin, Biochemical Reagents and Assay Development, GlaxoSmithKline Research and Development, Research Triangle Park, NC

Priya Kunapuli, In Vitro Sciences, External Discovery and Preclinical Sciences, Merck & Co., West Point, PA

Christopher Langmead, Heptares Therapeutics Limited, BioPark, Welwyn Garden City, UK

Angélique Levoye, Unité de Pathogénie Virale, Department of Virology, Institut Pasteur, Paris, France

Fiona H. Marshall, Heptares Therapeutics Limited, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire, UK

Lauren T. May, The University of Nottingham, Institute of Cell Signalling, School of Biomedical Sciences, Queen's Medical Centre, Nottingham, UK

Maria Rosa Mazzoni, Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy

Laurence J. Miller, Department of Molecular Pharmacology and Experimental Therapeutics Mayo Clinic, Scottsdale, AZ

Oliver Nayler, Actelion Pharmaceuticals Ltd., Allschwil, Switzerland

Terry Reisine, Independent Consultant, Los Angeles, CA

Patricia René, Département de Biochimie, Université de Montréal, Montréal, Quebec, Canada

Kimberly A. Reynolds, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX

Michael Sabio, Lundbeck Research USA, Paramus, NJ

Gunnar Schulte, Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

Patrick M. Sexton, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Victoria, Australia

John Simms, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Victoria, Australia

Elodie Tenconi, Institut Cochin, Université Paris Descartes, Department of Cell Biology, Paris, France

Sidney W. Topiol, Lundbeck Research USA, Paramus, NJ

Celine Valant, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Victoria, Australia

Kenneth J. Valenzano, Amicus Therapeutics, Cranbury, NJ

0 0

Post a comment